Funding, News and Announcements

» Go to news main

Pfizer: Advances in Management of Ulcerative Colitis

Posted by Jaq-Lin Larder on June 17, 2024 in Research Funding

This competitive program seeks to encourage organizations to submit grant applications for independent medical education initiatives that will increase healthcare professional’s understanding of patients living with Ulcerative Colitis

Potential applicants are encouraged to identify and address the educational needs of healthcare professionals to increase understanding of:

  • S1P receptor modulators mechanism of action (MoA) in UC;
  • Oral Small Molecules (S1P receptor modulators and/or JAK inhibitors) in the clinical management of moderate to severe UC and placement in the treatment algorithm.
  • S1P receptor modulators pre-first dose assessment and current clinical management standard of care.
  • Burden of disease and unmet needs in adolescents / young patients with UC and role of transition clinic’.
  • Burden of disease, unmet needs and treatment landscape in isolated proctitis.

Individual projects requesting up to $100,000 will be considered.

Full details are available here.


Contact Details

External: Amanda Stein (, with the subject line “UC Education.”


Internal: July 23, 2024
External: August 7, 2024

The grants facilitator for your faculty can be found on the staff contact page. For additional resources, click here for guidance on internal deadlines and submission processes.